Ovid Application Error
Weighing Risks and Benefits of Liraglutide - The FDA's Review of a New Antidiabetic Therapy. Parks, Mary M.D.; Rosebraugh, Curtis M.D., M.P.H. [Miscellaneous Article] New England Journal of Medicine. 362(9):774-777, March 4, 2010.
(Format: HTML, PDF)